학술논문

A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocationassociated recurrent/metastatic sarcomas-NCIC-CTG IND 200
Document Type
Article
Source
In: Annals of Oncology. (Annals of Oncology, 1 May 2015, 26(5):973-981)
Subject
Language
English
ISSN
15698041
09237534